Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IMV Inc IMVIF

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIF - Post by User

IMV Inc > COVID-19 Trials
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(17)
•••
Comment by alphaseeking001on Dec 21, 2020 2:58pm
201 Views
Post# 32154294

RE:RE:RE:RE:RE:RE:COVID-19 Trials

RE:RE:RE:RE:RE:RE:COVID-19 TrialsI've been in IMV long enough to see these kind of unwarranted significant percentage drops many times.  I truly feel it's mostly due to tax-loss selling this year.  That massive volume spike (60million plus shares in a day) at much higher levels in July absolutely set us up for significantly more potential tax-loss selling than normal.  The recent clinical updates in oncology have been quite good IMHO.  If you don't have to sell down here, it might be worth actually picking some up.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities